Generic Name: Pembrolizumab for Hodgkin's Lymphoma ()
Pembrolizumab for Hodgkin's Lymphoma Reviews
Keytruda (pembrolizumab) "Recurrent Hodgkin lymphoma and Keytruda put me in remission immediately, first infusion. It is a miracle drug for many! However, side effects after 7 months of treatment were becoming unbearable and ceased. Skin and lung issues from first month. Been 3 months since stopping infusions and seem to be improving!"
More about pembrolizumab
- Check interactions
- Compare alternatives
- Reviews (248)
- Side effects
- Dosage information
- During pregnancy
- Drug class: anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
- Breastfeeding
- En español
Patient resources
- Pembrolizumab drug information
Other brands
Keytruda
Professional resources
- Pembrolizumab monograph
Other brands
Keytruda
Related treatment guides
- Bladder Cancer
- Breast Cancer
- Biliary Tract Tumor
- Cervical Cancer
